NEXGEL to Participate in the IAccess Alpha Virtual Best Ideas Winter Conference on December 10-11, 2024

GlobeNewswireNov 21 09:00 ET

Express News | Korro Bio Has Received Approval From The Australian Bellberry Human Research Ethics Committee And Clearance From The Australian Therapeutic Goods Administration To Initiate A Phase 1/2a Study Of KRRO-110 For Alpha-1 Antitrypsin Deficiency

BenzingaNov 21 07:47 ET

Arqaam Capital Cuts Alpha Dhabi PT, Maintains at Hold

MT NewswiresNov 21 07:30 ET

Korro Receives Australian HREC Approval and CTN Clearance to Initiate Phase 1/2a Clinical Study (REWRITE) of KRRO-110 for Alpha-1 Antitrypsin Deficiency

GlobeNewswireNov 21 07:30 ET

Congenital Adrenal Hyperplasia Landscape Research 2024: Comprehensive Insights About 8+ Pipeline Drugs Featuring Neurocrine Biosciences, Spruce Biosciences, Lundbeck, and HBM Alpha Therapeutics

Yahoo FinanceNov 21 04:06 ET

Deutsche Bank Invests in German AI Startup Aleph Alpha as Other Backers Grow Stakes

WSJNov 20 10:56 ET